ELITE PHARMACEUTICALS INC /NV/ Annual Weighted Average Number of Shares Outstanding, Diluted from 2011 to 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Elite Pharmaceuticals Inc /Nv/ quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2011 to 2023.
  • Elite Pharmaceuticals Inc /Nv/ Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 1.07B shares, a 4.8% increase year-over-year.
  • Elite Pharmaceuticals Inc /Nv/ annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 1.02B shares, a 1.02% increase from 2022.
  • Elite Pharmaceuticals Inc /Nv/ annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 1.01B shares, a 0.23% increase from 2021.
  • Elite Pharmaceuticals Inc /Nv/ annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 1.01B shares, a 7.17% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 1.02B +10.3M +1.02% Apr 1, 2023 Mar 31, 2024 10-K 2024-07-01
2022 1.01B +2.3M +0.23% Apr 1, 2022 Mar 31, 2023 10-K 2024-07-01
2021 1.01B +67.6M +7.17% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-29
2020 943M -50.3M -5.06% Apr 1, 2020 Mar 31, 2021 10-K 2022-06-29
2019 993M +177M +21.7% Apr 1, 2019 Mar 31, 2020 10-K 2021-06-14
2018 816M +18.1M +2.27% Apr 1, 2018 Mar 31, 2019 10-K 2020-06-30
2017 798M -46.3M -5.49% Apr 1, 2017 Mar 31, 2018 10-K 2019-06-21
2016 845M +171M +25.3% Apr 1, 2016 Mar 31, 2017 10-K 2018-06-14
2015 674M -83.7M -11% Apr 1, 2015 Mar 31, 2016 10-K 2018-06-14
2014 758M +295M +63.6% Apr 1, 2014 Mar 31, 2015 10-K 2017-06-14
2013 463M -63.9M -12.1% Apr 1, 2013 Mar 31, 2014 10-K 2016-06-15
2012 527M +268M +103% Apr 1, 2012 Mar 31, 2013 10-K 2014-06-30
2011 259M Apr 1, 2011 Mar 31, 2012 10-K 2013-06-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.